M1 muscarinic receptors stimulate rapid and prolonged phases of neuronal nitric oxide synthase activity: Involvement of different calcium pools

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 487-497

  Wotta, Diane R ^a   Parsons, Ann M ^a   Hu, Jingru ^a   Grande, Andrew W ^a   El Fakahany, Esam E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholine; Calcium; Muscarinic system; Receptor; Signaling

Indexed keywords

ARGININE; CALCIUM ION; CITRULLINE; MUSCARINIC M1 RECEPTOR; NITRIC OXIDE SYNTHASE; ACETYLCHOLINE; CALCIUM; CARBACHOL; CHELATING AGENT; CYCLIC GMP; CYTIDYLYL ADENOSINE; DIAGNOSTIC AGENT; DINUCLEOSIDE PHOSPHATE; EGTAZIC ACID; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NERVE PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS1 PROTEIN, RAT; TRITIUM;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CHO CELL; ENZYME ACTIVATION; ENZYME MECHANISM; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; KINETICS; METABOLISM; MUTAGENESIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

ACETYLCHOLINE; ANIMALS; CALCIUM; CARBACHOL; CHELATING AGENTS; CHO CELLS; CITRULLINE; CRICETINAE; CYCLIC GMP; DINUCLEOSIDE PHOSPHATES; EGTAZIC ACID; ENZYME ACTIVATION; HUMANS; KINETICS; MUSCARINIC AGONISTS; MUTAGENESIS; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; TRANSFECTION; TRITIUM;

EID: 0031595281     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020487.x     Document Type: Article

References (42)

1. Aoki E., Takeuchi I. K., and Shoji R. (1995) Nitric oxide: an attractive signaling molecule. Acta Histochem. Cytochem. 28, 97-106.
2. Berridge M. J. (1993) Inositol trisphosphate and calcium signaling. Nature 361, 315-325.
3. Bredt D. S. (1995) Molecular characterization of nitric oxide synthase, in Nitric Oxide in the Nervous System (Vincent S. R., ed), pp. 1-19. Academic Press, San Diego.
4. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86, 9030-9033.
5. Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
6. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M., and Snyder S. H. (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7, 615-624.
7. Bymaster F. P., Whitesitt C. A., Shannon H. E., DeLapp N., Ward J. S., Calligaro D. O., Shipley L. A., Buelke-Sam J. L., Bodick N. C., Farde L., Sheardown M. J., Olesen P. H., Hansen K. T., Suzdak P. D., Swedberg M. D. B., Sauerberg P., and Mitch C. H. (1997) Xanomeline: a selective muscarinic agonist for the treatment of Alzheimer's disease. Drug Dev. Res. 40, 158-170.
8. Castoldi A. F., Manzo L., and Costa L. G. (1993) Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures. Brain Res. 610, 57-61.
9. Caulfield M. P. (1993) Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther. 58, 319-379.
10. Cioffi C. L. and El-Fakahany E. E. (1989) Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Biochem. Pharmacol. 38, 1827-1834.
11. 1 receptor stimulation. J. Neurochem. 71, 571-579.
12. Ehlert F. J., Roeske W. R., and Yamamura H. I. (1995) Molecular biology, pharmacology, and brain distribution of subtypes of the muscarinic receptor, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 111-123. Raven Press, New York.
13. El-Fakahany E. E. and Richelson E. (1980) Regulation of muscarinic receptor-mediated cyclic GMP synthesis by cultured mouse neuroblastoma cells. J. Neurochem. 35, 941-948.
14. Feigenbaum P. and El-Fakahany E. E. (1985) Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function. J. Pharmacol. Exp. Ther. 233, 134-140.
15. Felder C. C., MacArthur L., Ma A. L., Gusovsky F., and Kohn E. C. (1993) Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx. Proc. Natl. Acad. Sci. USA 90, 1706-1710.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
17. Hu J. and El-Fakahany E. E. (1993) Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J. Neurochem. 61, 578-585.
18. Hu J. and El-Fakahany E. E. (1995) Anomalous increase in nitric oxide synthase activity by certain nitric oxide-generating compounds in intact neuronal cells. J. Neurochem. 65, 117-124.
19. Hu J. and El-Fakahany E. E. (1996) Intricate regulation of nitric oxide synthesis in neurons. Cell. Signal. 8, 185-189.
20. Hu J., Wang S.-Z., and El-Fakahany E. E. (1991) Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 257, 938-945.
21. Knowles R. G., Palacios M., Palmer R. M., and Moncada S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86, 5159-5162.
22. Kuo P. C. and Schroeder R. A. (1995) The emerging multifaceted roles of nitric oxide. Ann. Surg. 221, 220-235.
23. Lee L. Y., Zhu S. Z., and El-Fakahany E. E. (1996) Role of two highly conserved tyrosine residues in the ml muscarinic receptor second transmembrane domain in ligand binding and receptor function. Recept. Signal Transduct. 6, 43-52.
24. 2+ influx. J. Neurosci. 16, 1702-1709.
25. Matsuzawa H. and Nirenberg M. (1975) Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Biochemistry 72, 3472-3476.
26. 2+. J. Neurochem. 59, 2024-2029.
27. McKinney M., Stenstrom S., and Richelson E. (1985) Muscarinic responses and binding in murine neuroblastoma clone (N1E-115) mediation of separate responses by high affinity and low affinity agonist-receptor conformations. Mol. Pharmacol. 27, 223-235.
28. 2+ influx following receptor activation. Trends Pharmacol Sci. 12, 289-292.
29. Nathan C. (1992) Nitric oxide as a secretary product of mammalian cells. FASEB J. 6, 3051-3064.
30. Paakkari I. and Lindsberg P. (1995) Nitric oxide in the central nervous system. Ann. Med. 27, 369-377.
31. Putney J. W. Jr. (1993) Excitement about calcium signaling in inexcitable cells. Science 262, 676-678.
32. Richelson E. (1978) Desensitization of muscarinic receptor-mediated cyclic GMP formation by cultured nerve cells. Nature 272, 366-368.
33. 2+ in the down-regulation of cGMP signaling. Biochem. Pharmacol. 50, 763-769.
34. j-increasing agents cyclopiazonic acid and thapsigargin. J. Biol. Chem. 269, 8786-8791.
35. 2+ mobilization in muscarinic and histamine receptor-mediated activation of guanylate cyclase in N1E-115 neuroblastoma cells: assessment of the arachidonic acid release hypothesis. Mol. Pharmacol. 37, 860-869.
36. Wang S. Z. and El-Fakahany E. E. (1993) Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J Pharmacol. Exp. Ther. 266, 237-243.
37. Wang S. Z., Zhu S. Z., and El-Fakahany E. E. (1994) Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J. Pharmacol. Exp. Ther. 268, 552-557.
38. Wang S. Z., Lee S. Y., Zhu S. Z., and El-Fakahany E. E. (1996) Differential coupling of m1, m3 and m5 muscarinic receptors to activation of neuronal nitric oxide synthase. Pharmacology 53, 271-280.
39. Wang S. Z., Lee S. Y., Zhu S. Z., Wotta D. R., Parsons A. M., and El-Fakahany E. E. (1997) Activation of neuronal nitric oxide synthase by M2 muscarinic receptors associated with a small increase in intracellular calcium. Pharmacology 55, 10-17.
40. Wotta D. R. and El-Fakahany E. E. (1997) Muscarinic receptor-mediated activation of nitric oxide synthase. Drug Discovery Res. 40, 205-214.
41. Wotta D. R., Birnbaum A. K., Wilcox G. L., Elde R., and Law P. Y. (1997) μ-Opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner. Mol. Brain Res. 44, 55-65.
42. Zhu S. Z., Wang S. Z., Hu J., and El-Fakahany E. E. (1994) An arginine residue conserved in most G protein-coupled receptors is essential for the function of the M1 muscarinic receptor. Mol. Pharmacol. 45, 517-523.